New painkiller shows promise for Post-Surgery relief

NCT ID NCT06887972

Completed Symptom relief Sponsor: Vertex Pharmaceuticals Incorporated Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the effectiveness and safety of a medicine called suzetrigine, used together with other pain treatments, for acute pain after cosmetic or reconstructive surgery. About 100 adults took part. The goal was to see if patients rated their pain control as good, very good, or excellent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE PAIN

Contacts and locations

Locations

Atlanta Center for Medical Research

Atlanta, Georgia, 30331, United States
Beth Israel Deaconess Medical Center - Surgery

Boston, Massachusetts, 02215, United States
HD Research LLC | First Surgical Hospital

Bellaire, Texas, 77401, United States
JBR Clinical Research

Salt Lake City, Utah, 84107, United States
Memorial Hermann Village

Houston, Texas, 77043, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.